SWM
AUPH icon

Spire Wealth Management’s Aurinia Pharmaceuticals AUPH Stock Holding History

Spire Wealth Management’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.4K Hold
672
– – ﹤0.01% 1607
2026
Q1 		$9.96K Sell
672
-217
-24% -$3.17K ﹤0.01% 1613
2025
Q4 		$14.2K Sell
889
-124
-12% -$1.76K ﹤0.01% 1605
2025
Q3 		$11.2K Sell
1,013
-428
-30% -$4.67K ﹤0.01% 1710
2025
Q2 		$12.2K Hold
1,441
– – ﹤0.01% 1654
2025
Q1 		$11.6K Hold
1,441
– – ﹤0.01% 1794
2024
Q4 		$12.9K Hold
1,441
– – ﹤0.01% 1769
2024
Q3 		$10.6K Hold
1,441
– – ﹤0.01% 1612
2024
Q2 		$8.23K Sell
1,441
-650
-31% -$3.42K ﹤0.01% 1696
2024
Q1 		$10.5K Hold
2,091
– – ﹤0.01% 1700
2023
Q4 		$16.7K Hold
2,091
– – ﹤0.01% 1593
2023
Q3 		$16.2K Buy
2,091
+650
+45% +$6.36K ﹤0.01% 1581
2023
Q2 		$13.9K Hold
1,441
– – ﹤0.01% 1712
2023
Q1 		$15.8K Hold
1,441
– – ﹤0.01% 1703
2022
Q4 		$6K Hold
1,441
– – ﹤0.01% 1760
2022
Q3 		$11K Sell
1,441
-400
-22% -$3.46K ﹤0.01% 1526
2022
Q2 		$19K Hold
1,841
– – ﹤0.01% 1683
2022
Q1 		$23K Sell
1,841
-20
-1% -$309 ﹤0.01% 1749
2021
Q4 		$43K Buy
1,861
+320
+21% +$7.58K ﹤0.01% 1796
2021
Q3 		$34K Hold
1,541
– – ﹤0.01% 1632
2021
Q2 		$20K Buy
1,541
+236
+18% +$3.01K ﹤0.01% 1862
2021
Q1 		$17K Buy
+1,305
New +$18.9K ﹤0.01% 2206

Other funds holding AUPH

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Spire Wealth Management's AUPH Position: Q2 2026 in Review

Spire Wealth Management held its Aurinia Pharmaceuticals (AUPH) position steady in Q2 2026 at 672 shares worth $11.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1607.

Spire Wealth Management first reported a position in AUPH in Q1 2021 and has held it in 22 quarters since. The position peaked at $43K in Q4 2021. 281 funds tracked by Wall St. Rank hold AUPH as of Q2 2026.

  • Spire Wealth Management held 672 shares of Aurinia Pharmaceuticals worth $11.4K as of Q2 2026.
  • Spire Wealth Management left its Aurinia Pharmaceuticals share count unchanged in Q2 2026.
  • Aurinia Pharmaceuticals made up ﹤0.01% of Spire Wealth Management's portfolio in Q2 2026, its #1607 holding.
  • Spire Wealth Management first reported a position in Aurinia Pharmaceuticals in Q1 2021 and has held it in 22 quarters since.
  • Spire Wealth Management's Aurinia Pharmaceuticals position peaked at $43K in Q4 2021.
  • 281 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q2 2026.

Based on Spire Wealth Management's 13F filing for Q2 2026, filed 15 Jul 2026.